Van Oene Mark sold PACB
March 3, 2026 · Form 4 insider transaction
Van Oene Mark sold 6,504 shares of Pacific Biosciences of California, Inc. at $1.51 per share, a transaction worth $9.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Represents the number of shares mandatorily sold to cover tax withholding obligations in connection with the vesting of restricted stock units.; This sale price represents the weighted average sale price of the shares sold ranging from $1.49 to $1.56 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.; Includes 7,500 shares purchased on March 2, 2026 under the Company's 2010 Employee Stock Purchase Plan.